Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, December 21, 2023
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
[ Thu, Dec 21st 2023
] - WOPRAI
Kevin Caliendo Maintained (ALHC) at Hold with Increased Target to $9 on, Dec 21st, 2023
Kevin Caliendo of UBS, Maintained "Alignment Healthcare, Inc." (ALHC) at Hold with Increased Target from $6.5 to $9 on, Dec 21st, 2023.
Kevin has made no other calls on ALHC in the last 4 months.
There are 4 other peers that have a rating on ALHC. Out of the 4 peers that are also analyzing ALHC, 2 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Kevin Fischbeck of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $7.25 on, Thursday, November 2nd, 2023
- Scott Fidel of "Stephens & Co." Initiated at Hold and Held Target at $9 on, Thursday, October 12th, 2023
These are the ratings of the 2 analyists that currently disagree with Kevin
- John Ransom of "Raymond James" Upgraded from Buy to Strong Buy and Increased Target to $10 on, Monday, October 16th, 2023
- Ricky Goldwasser of "Morgan Stanley" Maintained at Buy with Decreased Target to $12 on, Wednesday, August 30th, 2023
